Recent Headlines
AnaSpec Introduces 12 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added twelve (12) new antibodies to its growing collection of catalog antibodies. The targeted research area for these antibodies is signal transduction and matrix... - July 26, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Ten New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new peptides for drug discovery research. MUC4 - Cat# 61339 This peptide is derived from the tandem repeat of Muc 4 mucin protein. Mucins are highly O-glycosylated proteins which... - July 25, 2007 - AnaSpec, EGT Group
Xcelience Expanding Operations
The Tampa-based contract research organization acquires a brand new building. - July 23, 2007 - Xcelience, LLC
AnaSpec Introduces Eleven New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eleven (11) new peptides for drug discovery research. - July 22, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New Selection of Cathelicidin Peptides
Cathelicidins are cationic peptides that have broad-range antimicrobial activity. These peptides belong to the family of anti-microbial peptides which form part of the host’s important innate immunity mechanism. - July 20, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Anti-MMP-1 & Anti-MMP-13 (Hinge) Antibodies
AnaSpec has introduced its newest antibody solutions – anti-MMP-1 (Hinge) and anti-MMP-13 (Hinge) antibodies. Strategically raised against the hinge regions of MMP-1 and MMP-13, the epitopes do not overlap the catalytic domain and will not influence the activity of the MMP ferment in... - July 19, 2007 - AnaSpec, EGT Group
American Peptide Symposium Poster Describes Synthesis of Hydrocarbon-Stapled Peptides
At the 2007 annual conference of the American Peptide Society, AnaSpec presented a technical poster that described the facile synthesis of a hydrocarbon-stapled peptide. Asymmetric synthesis of (S)-Fmoc-α-(2’-pentenyl)-alanine was successfully accomplished via an Ala-Ni (II)-BPB-complex... - July 14, 2007 - AnaSpec, EGT Group
AnaSpec Presents Late-Breaking In Vivo Imaging Poster at American Peptide Symposium
At the 2007 annual conference of the American Peptide Society, AnaSpec presented a “late-breaking” technical poster that described in vivo imaging using a tissue-specific near infrared fluorescent peptide conjugate. Extracellular matrix proteins that contain the Arg-Gly-Asp (RGD)... - July 13, 2007 - AnaSpec, EGT Group
PharmaChem Publishes AnaSpec Article on Peptides as Antigens
The June issue of PharmaChem, an Italian journal covering the drug discovery industry, featured an article written by AnaSpec called “Peptides as Antigens.” The technical article, written by Dr. Daniel Li and Cecilia Po, outlines the advantages and methodologies behind using peptides as... - June 24, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte™ Beta-Secretase Assay Kit
Leveraging one of the world’s largest collections of amyloid peptides, AnaSpec has introduced its latest development in novel solutions for amyloid-related research - the new SensoLyte™ 520 Beta-Secretase Assay Kit. Beta-secretase catalyzes a key step in the production of beta-amyloid... - June 22, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Industry’s First and Only Anti-MOG ELISA Kits
Drawing on its broad portfolio of MOG (35-55) and other multiple sclerosis (MS) experimental autoimmune encephalomyelitis (EAE)-related peptides, AnaSpec has just released its new line of SensoLyte™ Anti - MOG ELISA Kits - the industry’s first and only anti-MOG ELISA kits. Myelin... - June 16, 2007 - AnaSpec, EGT Group
AnaSpec Prepares Technical Poster about Beta-Secretase Assay for Experimental Biology 2007
At the 2007 Experimental Biology conference in Washington, DC, AnaSpec prepared a technical poster entitled, "A Sensitive Fluorimetric Assay for Detection of beta-Secretase Activity Using a Novel FRET Peptide Substrate." The poster documented the following findings: • A highly... - June 08, 2007 - AnaSpec, EGT Group
Novel Agent for Reactive Metabolite Detection
Bioactivation of drug candidates resulting in chemically reactive, electrophilic metabolites have always presented a major challenge to pharmaceutical companies. Moreover, the measurement of these metabolites has been hampered by the lack of an effective quantitative method. QA-GSH is a novel new... - May 31, 2007 - AnaSpec, EGT Group
Xcelience Will Acquire New Technologies to Enhance Drug Development Processes
The Tampa-based Contract Research Organization signed a partnership that will form new opportunities in the pharmaceutical industry. - May 24, 2007 - Xcelience, LLC
AnaSpec Introduces Line of Insulin Receptor Antibodies
The insulin receptor is a transmembrane receptor that belongs to the tyrosine kinase receptors class. It is a heterotetrameric glycoprotein composed of disulfide-linked subunits in a β-α-α-β configuration. This transmembrane receptor consists of 95kDa β-subunit, a single... - May 23, 2007 - AnaSpec, EGT Group
Industry’s First West Nile Virus Protease Assay Kits
While West Nile virus (WNV) has had significant outbreaks throughout the world since it was first identified, commercially available assay kits for the detection of WNV protease inhibitors had not been developed until now. With the SensoLyte™ series of WNV Protease Assay Kits AnaSpec, a... - May 17, 2007 - AnaSpec, EGT Group
Interleukin & Chemokine Antibodies – Two Types of Cytokine Antibodies
Interleukin-32 (IL-32), whose expression is increased following activation by IL-2, was initially identified as a transcript (NK4) selectively expressed in lymphocytes and NK cells.1 - April 18, 2007 - AnaSpec, EGT Group
ABRF Poster Presents Comparison of Fluorescent Peptide Synthesis Methods
At the 2007 annual conference of the Association of Biomolecular Resource Facilities, AnaSpec presented a technical poster that compared the synthesis of a fluorescent peptide using two types of resins. The results of the poster indicated that the use of an unprotected resin was just as effective... - April 13, 2007 - AnaSpec, EGT Group
New Dye Solution for Far Red to NIR Imaging
Utilizing its proprietary HiLyte Fluor™ technology, AnaSpec has introduced dye solutions for far red to NIR imaging. AnaSpec’s HiLyte Fluor™ 647, HiLyte Fluor™ 680, and HiLyte Fluor™ 750 provide AnaSpec with a range of dyes that cover the spectrum. AnaSpec has also... - April 11, 2007 - AnaSpec, EGT Group
AnaSpec Introduces AnaTag™ Protein Labeling Kits
The labeling of proteins and antibodies with fluorescent dyes can play a crucial role in flow cytometry, immunohistochemistry and fluorescent in-situ hybridization techniques. Incorporating its high performance HiLyte Fluor™ dyes in a ready-to-use kit, AnaSpec has introduce its new line of... - April 04, 2007 - AnaSpec, EGT Group
AnaSpec Launches Optimized Website
In an effort to optimize the online experience of its customers, AnaSpec, a worldwide provider of integrated proteomics solutions, has moved its website to a faster, dedicated server. AnaSpec sales & marketing manager, Violeta Rajkovska, MBA, stated, “With the huge number of catalog... - March 28, 2007 - AnaSpec, EGT Group
Two Leading Biotech Publications Report on Advaxis’ Listeria Platform Technology
Advaxis’ John Rothman Recognized as one of 20 Notable People in R&D - March 16, 2007 - Advaxis
Name Change: AnaSpec’s EnzoLyte is now SensoLyte™
AnaSpec, a worldwide provider of integrated proteomics solutions, announced today that the name of their flagship line of high-performance assay kits has been changed from EnzoLyte to SensoLyte™. AnaSpec sales & marketing manager, Violeta Rajkovska, MBA, noted, “The new name... - March 14, 2007 - AnaSpec, EGT Group
Xcelience Employs "CFS1200 Capsule Filling and Sealing Machine"
Xcelience's implementation of the CFS1200 will allow its formulation scientists the opportunity to accelerate the drug development timeframe. - March 13, 2007 - Xcelience, LLC
Xcelience Completes Successful QP Audit of Production Facility for European Market
Xcelience achives its third successful audit. - March 09, 2007 - Xcelience, LLC
Xcelience Debuts its Innovative and Interactive Forum: XpertXchange™
XpertXchange will initiate dialogue between Xcelience scientists and drug development professionals. - March 02, 2007 - Xcelience, LLC
Creating New Life Forms that May Help Eradicate Cancer Affecting Women
Instead of using the usual cancer-fighting modalities, surgery, chemotherapy, or radiation, researchers from a drug development company called Advaxis, have embarked on a novel approach to fighting cancer: Engaging the immune system to attack cancer in the same the way it would a flu vaccine, by... - February 27, 2007 - Advaxis
Xcelience Launches Drug Development Consulting Service
The launch of Xpert Consulting will provide supplemental services to assist clients. - January 17, 2007 - Xcelience, LLC
ASCB Poster Presents Immunocapture Techniques for Improved MMP Assay
At the annual conference of the American Society for Cell Biology, AnaSpec presented a technical poster documenting improved technology for MMP detection assays. In a previous poster, AnaSpec documented the use of highly sensitive FRET-peptide substrates for MMP detection. The latest poster... - December 19, 2006 - AnaSpec, EGT Group
Fluorinated Building Blocks Produce Molecules with Enhanced Physiological Activities
The substitution of the fluorine in place of hydrogen in building blocks, such as amino acids, has produced molecules with enhanced physiological activities (1-2). Some of these are antibacterial, antihypertensive and antitumoral (3). One reason for the enhanced activity is that fluorine forms a... - December 12, 2006 - AnaSpec, EGT Group
Swiss Medica to Pursue Military and International Contracts with the Appointment of Christensen Co. as Strategic Business Advisors
Swiss Medica, Inc. (OTCBB: SWME) announced today its intention to pursue military and international contracts with the appointment of Mr. Chad Christensen, Managing Director of Christensen Co., as Strategic Business Advisor. With a distinguished career in international banking, and advisor to... - July 30, 2006 - SwissMedica Support Group
AnaSpec Introduces New Line of Reagents and Kits for Study of Protein Phosphorylation
AnaSpec, a leading provider of integrated proteomics solutions, has introduced an extensive new line of reagents and kits for the study of protein phosphorylation. Cellular phosphorylation is a reversible, covalent modification of a protein or lipid that serves to modify the activity of the... - June 06, 2006 - AnaSpec, EGT Group
WellAware™ Error-Free Light Guided Manual Pipetting System is Now Application Based
BioTX has finished the development of an application based, light guided manual pipetting system called WellAware which is ideal for forensic, paternity, life science, pharmaceutical, preclinical and chemistry labs. WellAware provides lab managers with an inexpensive alternative or supplement to full automation. WellAware is configured right out of the box for PCR, DNA sequencing, genotyping, microplate transpositions, dilutions, normalizations, microplate reformatting and cherry-picking. - May 25, 2006 - BioTX Automation, Inc.
Cactus Botanics Increases the Production Capability of Policosanol
Cactus Botanics Limited, in cooperation with its Chinese manufacturing operations, has completed expansion of its production capabilities for Policosanol (Octacosanol 65%). - November 12, 2005 - Cactus Botanics Limited
Cactus Botanics Introduces Sesamin 90%
Cactus Botanics, a leading raw material supplier, announces the completion of development and introduction to the market of Sesamin 90% HPLC, currently the only Chinese supply of this level. - November 07, 2005 - Cactus Botanics Limited
TimTec 10-year Anniversary
TimTec Inc. is expressing customer and business partner appreciation as the company marks 10-years anniversary on the market of early drug-discovery. - October 17, 2005 - TimTec Corporation
Sigma-Aldrich Introduces the MyriaScreen Diversity Collection for Drug Discovery
Sigma-Aldrich (NASDAQ:SIAL) is pleased to announce the availability of the MyriaScreen Diversity Collection of drug-like screening compounds. The collection, produced in collaboration with TimTec Inc. (http://www.timtec.net), is the result of careful evaluation, filtering, and refinement of selections from each of our screening compound collections. - September 23, 2005 - TimTec Corporation
Cactus Botanics Leads in Drafting Quality Standards for Fucoidan Content
Cactus Botanics offers three specifications of Brown Seaweed with active ingredient Fucoidan and leads in drafting quality standards for assay of Fucoidan content. - August 29, 2005 - Cactus Botanics Limited